Oatly Group (NASDAQ:OTLY – Get Free Report) will be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect Oatly Group to post earnings of ($0.06) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
Oatly Group Trading Up 0.7 %
Shares of Oatly Group stock opened at $0.81 on Tuesday. Oatly Group has a fifty-two week low of $0.50 and a fifty-two week high of $1.40. The firm has a market cap of $479.56 million, a PE ratio of -1.15 and a beta of 2.09. The business’s fifty day moving average is $0.86 and its two-hundred day moving average is $0.96. The company has a quick ratio of 0.53, a current ratio of 0.68 and a debt-to-equity ratio of 0.62.
Analyst Ratings Changes
OTLY has been the subject of a number of research analyst reports. Royal Bank of Canada restated a “sector perform” rating and set a $1.05 price objective on shares of Oatly Group in a report on Thursday, July 25th. BNP Paribas upgraded Oatly Group from a “neutral” rating to an “outperform” rating in a report on Thursday, July 25th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $1.45.
Oatly Group Company Profile
Oatly Group AB, an oatmilk company, provides a range of plant-based dairy products made from oats in Europe, the Middle East, Africa, the Americas, and Asia. It offers Barista edition oatmilk, oatgurts, frozen desserts, ice-creams, and yogurts; cooking products, including cooking cream, in regular and organic, Crème Fraiche, whipping cream, vanilla custard, and spreads in a variety of flavors; and ready-to-go drinks.
See Also
- Five stocks we like better than Oatly Group
- What is the Nikkei 225 index?
- Intel: Is Now the Time to Be Brave?
- How to Effectively Use the MarketBeat Ratings Screener
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Average Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Oatly Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oatly Group and related companies with MarketBeat.com's FREE daily email newsletter.